Cargando…

How previous treatment changes the metabolomic profile in patients with metastatic breast cancer

PURPOSE: Metabolites are in the spotlight of attention as promising novel breast cancer biomarkers. However, no study has been conducted concerning changes in the metabolomics profile of metastatic breast cancer patients according to previous therapy. METHODS: We performed a retrospective, single-ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nees, Juliane, Schafferer, Simon, Yuan, Baowen, Tang, Quiqong, Scheffler, Matthias, Hartkopf, Andreas, Golatta, Michael, Schneeweiß, Andreas, Burwinkel, Barbara, Wallwiener, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Gynecologic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633507/ https://www.ncbi.nlm.nih.gov/pubmed/35467121 http://dx.doi.org/10.1007/s00404-022-06558-5

Ejemplares similares

Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer
por: Fischer, Chiara, et al.
Publicado: (2022)

Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer
por: von Au, Alexandra, et al.
Publicado: (2022)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

Impact of age on indication for chemotherapy in early breast cancer patients: results from 104 German institutions from 2008 to 2017
por: Hoffmann, Ann Sophie, et al.
Publicado: (2023)

Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification
por: Wallwiener, Markus, et al.
Publicado: (2012)

HER2-targeted therapy influences CTC status in metastatic breast cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

The impact of rehabilitation sport on breast cancer-related lymphoedema and quality of life
por: Boeer, Bettina, et al.
Publicado: (2022)

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients
por: Wallwiener, Markus, et al.
Publicado: (2014)

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
por: Wallwiener, Markus, et al.
Publicado: (2015)

Learning curve for laparoscopic staging of early and locally advanced cervical and endometrial cancer
por: Tahmasbi Rad, Morva, et al.
Publicado: (2013)

Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study
por: Schuhn, Anne, et al.
Publicado: (2022)

Fertility preserving management of early endometrial cancer in a patient cohort at the department of women’s health at the university of Tuebingen
por: Andress, Jürgen, et al.
Publicado: (2021)

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer
por: Walter, Vincent, et al.
Publicado: (2020)

The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer
por: Stefanovic, Stefan, et al.
Publicado: (2020)

Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases
por: Lukac, Stefan, et al.
Publicado: (2023)

Surgeon’s preference of subcutaneous tissue resection: most important factor for short-term complications in subcutaneous implant placement after mastectomy—results of a cohort study
por: Pfob, André, et al.
Publicado: (2020)

Gynecologic oncologists’ attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
por: Klein, Evelyn, et al.
Publicado: (2017)

Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment
por: Fischer, Chiara, et al.
Publicado: (2022)

Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany
por: Neis, F., et al.
Publicado: (2022)

NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
por: Sultova, Elena, et al.
Publicado: (2020)

How to make students satisfied with digital teaching? Investigative results from teaching evaluations in Gynecology and Obstetrics
por: Tietz, Steffen, et al.
Publicado: (2022)

A review of the problematic adhesion prophylaxis in gynaecological surgery
por: Hirschelmann, Anja, et al.
Publicado: (2011)

Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study
por: Brusniak, Katharina, et al.
Publicado: (2021)

Role of integrins in the metastatic spread of high-grade serous ovarian cancer
por: Krajnak, Slavomir, et al.
Publicado: (2021)

Evaluation of sonographic detectability of different markers within an in vitro simulation model of the axilla
por: Guergan, Selin, et al.
Publicado: (2021)

Treatment with Calcium Ionophore Improves The Results in Patients with Previous Unsuccessful Attempts at The Fertilization: A Cohort Study
por: Tejera, Alberto, et al.
Publicado: (2021)

Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT
por: von Wolff, Michael, et al.
Publicado: (2011)

Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor Cells
por: Stefanovic, Stefan, et al.
Publicado: (2019)

Large Conization—Retrospective Monocentric Results for Fertility Preservation in Young Women with Early Stage Cervical Cancer
por: Tsaousidis, Christos, et al.
Publicado: (2021)

The effect of radiotherapy on fat engraftment for complete breast reconstruction using lipofilling only
por: Heine, Norbert, et al.
Publicado: (2022)

Evolving trends in the surgical therapy of patients with endometrial cancer in Germany: analysis of a nationwide registry with special emphasis on perioperative outcomes
por: Roth, Katrin, et al.
Publicado: (2023)

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
por: Grill, Sabine, et al.
Publicado: (2020)

Autologous fat grafting for breast reconstruction after breast cancer: a 12-year experience
por: Kempa, Sally, et al.
Publicado: (2021)

Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients
por: Hartkopf, Andreas D, et al.
Publicado: (2017)

Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects
por: Albert, Veruschka, et al.
Publicado: (2022)

Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of Principle
por: Stefanovic, Stefan, et al.
Publicado: (2020)

Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence
por: Cheng, Jie, et al.
Publicado: (2017)

Gynecologists’ attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany
por: Grimm, Donata, et al.
Publicado: (2020)

Hospital versus individual surgeon’s performance in laparoscopic hysterectomy
por: Driessen, Sara R. C., et al.
Publicado: (2016)

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
por: von Au, Alexandra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s4bjo3j7l9lj61ts89sm8su0ch